Requirements for different pharmaceutical forms or dosages [Regulatives / Guidelines]

posted by Mauricio Sampaio  – Brazil, 2020-07-13 15:52 (1771 d 12:54 ago) – Posting: # 21683
Views: 2,337

Dear, what is the guideline from EMA that I would found the bioavailability requirements for different pharmaceutical forms or dosages?
For example, comparing tablet vs suspension (with same dosage), extende release vs immediate release, tablet 500 mg vs tablet 250 mg (with same drug).

Thank you for any help!

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,683 registered users;
78 visitors (0 registered, 78 guests [including 12 identified bots]).
Forum time: 04:46 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5